אנסטרוזול מדיטק 1 מ"ג
Land: Israel
Språk: hebraisk
Kilde: Ministry of Health
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
ANASTROZOLE 1 MG
Tilgjengelig fra:
SAM-ON LTD
ATC-kode:
L02BG03
Legemiddelform:
FILM COATED TABLETS
Administreringsrute:
PER OS
Produsert av:
HELM PHARMACEUTICALS GMBH, GERMANY
Terapeutisk gruppe:
ANASTROZOLE
Indikasjoner:
Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
Autorisasjon dato:
2011-01-01
